

HY-170843 · 50 mg
MedChemExpress · Cat: HY-170843
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/antitumor-agent-198.html
Description
Antitumor agent-198 Compound A3 exhibits cytotoxicity in head and neck squamous cell carcinoma HNSCC cells, that inhibits the proliferation of CAL27, HN6, HN30, SCC9 and SCC25 with IC50 of 4 nM-77 nM. Antitumor agent-198 inhibits the HNSCC cell migration, arrests the cell cycle, and induces apoptosis.







